Panobacumab (KBPA101) is a fully humanised monoclonal antibody targeting Pseudomonas aeruginosa, specifically targeting the O-polysaccharide (OPS) component of the bacterial outer membrane LPS. It is effective against certain drug-resistant strains of P. aeruginosa, reduces pulmonary inflammation, and enhances the clearance of bacteria from the lungs by neutrophils.
Reinheit:
98.60%
CAS Nummer:
[885053-97-4]
Target-Kategorie:
Antibacterial
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten